Results of multicentral external quality assessment for M. tuberculosis drug susceptibility testing in Russia Source: Eur Respir J 2005; 26: Suppl. 49, 646s Year: 2005
Mycobacterium tuberculosis drug resistance surveillance in BelarusSource: Eur Respir J 2005; 26: Suppl. 49, 199s Year: 2005
Surveillance of M. tuberculosis drug resistance in Russia Source: Eur Respir J 2001; 18: Suppl. 33, 513s Year: 2001
Multidrug resistance of M. tuberculosis and its infuence on treatment efficiency of new detected patients with pulmonary tuberculosis in penitentiary institutions of Belarus Source: Eur Respir J 2007; 30: Suppl. 51, 272s Year: 2007
Structure of M. tuberculosis drug resistance in penitentiary institutions of Belarus Source: Eur Respir J 2006; 28: Suppl. 50, 586s Year: 2006
Description of M. tb strains structure among new TB cases in Tomsk Oblast, Russia Source: Annual Congress 2006 - Epidemiology and management of multidrug-resistant tuberculosis (MDR-TB) Year: 2006
Genetic markers of multi-drug and extensive drug resistant M. tuberculosis in Kyrgyz Republic Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools Year: 2012
Microbiology of Mycobacterium tuberculosis and a new diagnostic test for TB Source: Eur Respir Mon 2012; 58: 1-13 Year: 2012
Drug resistance profiles of mycobacterium tuberculosis isolates in MDR pulmonary tuberculosis from a high burden developing country Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis Year: 2008
Primary drug resistance against mycobacterium tuberculosis in a high burden country Source: Eur Respir J 2006; 28: Suppl. 50, 587s Year: 2006
Mycobacterium tuberculosis detection rates by molecular genetic methods among patients with tuberculosis in the Russian Federation. Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities Year: 2019
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for countries with a low tuberculosis burden Source: International Congress 2016 – ERS publications: a focus on recent guidelines and task forces Year: 2016
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries Source: Eur Respir J 2015; 46: 1563-1576 Year: 2015
Molecular epidemiology of M. tuberculosis drug resistance in Europe Source: International Congress 2015 – The emergence of drug-resistant tuberculosis in Europe: no cure possible? Year: 2015
High incidence of the Beijing strains among multi drug resistance isolates of Mycobacterium tuberculosis from extra pulmonary tuberculosis cases in northern India Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012
Estimating costs for treating patients with multi-drug resistant tuberculosis (MDR TB) under the regional tuberculosis control program, Tomsk (Russia) Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015
Tuberculosis 1995–2004: evaluation of the resistance of mycobacterium tuberculosis to anti-TBC drugs in Greece Source: Eur Respir J 2006; 28: Suppl. 50, 589s Year: 2006
XDR and MDR-TB genetic markers of M. tuberculosis strains circulating in Kyrgyz Republic Source: Annual Congress 2011 - Challenges in tuberculosis control Year: 2011
The Improvement of tuberculosis infection control in prisons Source: Eur Respir J 2002; 20: Suppl. 38, 164s Year: 2002
External quality assessment of drug resistant TB testing in Russia Source: Eur Respir J 2002; 20: Suppl. 38, 361s Year: 2002